Dr. Reddy’s Lab’s Q2FY23 Quarter Results
Dr. Reddy’s Lab’s revenues grew 6% YoY in Q2FY23.
- 28 Oct 2022
- Dr. Reddy’s Lab reported 5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended September (Q2FY23). On a year-on-year (YoY) basis, it witnessed a growth of 6%.
- Its expenses for the quarter were up by 3% QoQ and 1% YoY.
- The net profit increased by 79% QoQ and 80% YoY.
- The earnings per share (EPS) of Dr. Reddy’s Lab stood at 67 during Q2FY23.
Dr. Reddy’s Lab’s Financial Statements for Q2FY23:
Total Income | 5,992 | 6,087 | 6,373 | 5% | 6% |
Total Expenses | 4,745 | 4,628 | 4,773 | 3% | 1% |
Profit before tax | 1,273 | 1,468 | 1,614 | 10% | 27% |
Tax | 277 | 279 | 499 | 79% | 80% |
Profit after tax | 996 | 1,189 | 1,114 | -6% | 12% |
Earnings per share | 59.9 | 71.5 | 67.0 |
Data Source: BSE, Company announcements
Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Open Demat Account
Open Demat Account